Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Drug and Alcohol Dependence
|
July 17, 2022
Multi-chemokine receptor antagonist RAP-103 inhibits opioid-derived respiratory depression, reduces opioid reinforcement and physical dependence, and normalizes opioid-induced dysregulation of mesolimbic chemokine receptors in rats
Angela R Bongiovanni, Pingwei Zhao, Saadet Inan, et al.
Neuropharmacology
|
January 25, 2025
Pharmacological characterization of the novel selective kappa opioid receptor agonists 10-Iodo-Akuammicine and 10-Bromo-akuammicine in mice
Kathryn Bland, Chongguang Chen, Peng Huang, et al.
Cannabis and Cannabinoid Research
|
July 6, 2022
The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor
Luciana M Leo, Rufaida Al-Zoubi, Dow P Hurst, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2025
Peripherally Restricted Fused Heterocyclic Peptidomimetic Multifunctional Opioid Agonists as Novel, Potent Analgesics
Haylee R Hammond, Prakash Chaudhari, Ashley Bunnell, et al.
Science Signaling
|
August 22, 2023
Convergent activation of Ca<sup>2+</sup> permeability in two-pore channel 2 through distinct molecular routes
Ryo Saito, Qianru Mu, Yu Yuan, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2023
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity Relationship
Laura Figuerola-Asencio, Paula Morales, Pingwei Zhao, et al.
Molecular Pharmacology
|
September 10, 2010
Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity
Pingwei Zhao, Haleli Sharir, Ankur Kapur, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Drug and Alcohol Dependence
|
July 17, 2022
Multi-chemokine receptor antagonist RAP-103 inhibits opioid-derived respiratory depression, reduces opioid reinforcement and physical dependence, and normalizes opioid-induced dysregulation of mesolimbic chemokine receptors in rats
Angela R Bongiovanni, Pingwei Zhao, Saadet Inan, et al.
Neuropharmacology
|
January 25, 2025
Pharmacological characterization of the novel selective kappa opioid receptor agonists 10-Iodo-Akuammicine and 10-Bromo-akuammicine in mice
Kathryn Bland, Chongguang Chen, Peng Huang, et al.
Cannabis and Cannabinoid Research
|
July 6, 2022
The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor
Luciana M Leo, Rufaida Al-Zoubi, Dow P Hurst, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2025
Peripherally Restricted Fused Heterocyclic Peptidomimetic Multifunctional Opioid Agonists as Novel, Potent Analgesics
Haylee R Hammond, Prakash Chaudhari, Ashley Bunnell, et al.
Science Signaling
|
August 22, 2023
Convergent activation of Ca<sup>2+</sup> permeability in two-pore channel 2 through distinct molecular routes
Ryo Saito, Qianru Mu, Yu Yuan, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2023
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity Relationship
Laura Figuerola-Asencio, Paula Morales, Pingwei Zhao, et al.
Molecular Pharmacology
|
September 10, 2010
Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity
Pingwei Zhao, Haleli Sharir, Ankur Kapur, et al.
Page
of 5